Mark T. Albrecht

518 total citations
13 papers, 417 citations indexed

About

Mark T. Albrecht is a scholar working on Molecular Biology, Infectious Diseases and Genetics. According to data from OpenAlex, Mark T. Albrecht has authored 13 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Genetics. Recurrent topics in Mark T. Albrecht's work include Bacillus and Francisella bacterial research (6 papers), Viral gastroenteritis research and epidemiology (3 papers) and Bacteriophages and microbial interactions (2 papers). Mark T. Albrecht is often cited by papers focused on Bacillus and Francisella bacterial research (6 papers), Viral gastroenteritis research and epidemiology (3 papers) and Bacteriophages and microbial interactions (2 papers). Mark T. Albrecht collaborates with scholars based in United States, United Kingdom and Netherlands. Mark T. Albrecht's co-authors include Neal L. Schiller, Andrea Keane‐Myers, Alfred Mateczun, John Pesce, Les Baillie, Tristan T. Beaudette, Jean M. J. Fréchet, Eric M. Bachelder, Kristy M. Ainslie and Kyle E. Broaders and has published in prestigious journals such as Analytical Biochemistry, Journal of Bacteriology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Mark T. Albrecht

13 papers receiving 393 citations

Peers

Countries citing papers authored by Mark T. Albrecht

Since Specialization

Citations

This map shows the geographic impact of Mark T. Albrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Albrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Albrecht more than expected).

Fields of papers citing papers by Mark T. Albrecht

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark T. Albrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Albrecht. The network helps show where Mark T. Albrecht may publish in the future.

Co-authorship network of co-authors of Mark T. Albrecht

This figure shows the co-authorship network connecting the top 25 collaborators of Mark T. Albrecht. A scholar is included among the top collaborators of Mark T. Albrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark T. Albrecht. Mark T. Albrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Partnering on vaccines to counter multi-drug resistant threats: Workshop proceedings, Biomedical Advanced Research and Development Authority 2022 ·Human Vaccines & Immunotherapeutics ·(unknown), (unknown), (unknown), Mark T. Albrecht, Daniel Wolfe	5
2	Model for Evaluating Antimicrobial Therapy To Prevent Life-Threatening Bacterial Infections following Exposure to a Medically Significant Radiation Dose 2022 ·Antimicrobial Agents and Chemotherapy ·Andrew J. Phipps, (unknown), Mark T. Albrecht, Vijay K. Singh, Mary J. Homer	12
3	DNA Electroporation of Multi-agent Vaccines Conferring Protection Against Select Agent Challenge: TriGrid Delivery System 2014 ·Methods in molecular biology ·Andrea Keane‐Myers, (unknown), Drew Hannaman, Mark T. Albrecht	5
4	Challenges, Progress, and Opportunities: Proceedings of the Filovirus Medical Countermeasures Workshop 2014 ·Viruses ·(unknown), Lucy Ward, Nicole Kilgore, (unknown), (unknown), Mark T. Albrecht, George W. Christopher, (unknown)	23
5	Animal Models for Francisella tularensis and Burkholderia Species 2013 ·Veterinary Pathology ·(unknown), Mark T. Albrecht, Christopher R. Houchens, (unknown), Thomas M. Dreier, Joseph C. Larsen	15
6	Electroporation of a multivalent DNA vaccine cocktail elicits a protective immune response against anthrax and plague 2012 ·Vaccine ·Mark T. Albrecht, Brian Livingston, John Pesce, (unknown), Drew Hannaman, Andrea Keane‐Myers	15
7	Immunogenicity and efficacy of an anthrax/plague DNA fusion vaccine in a mouse model 2012 ·FEMS Immunology & Medical Microbiology ·Mark T. Albrecht, Jim Eyles, Les Baillie, Andrea Keane‐Myers	11
8	Ultra-fast pg/ml anthrax toxin (protective antigen) detection assay based on microwave-accelerated metal-enhanced fluorescence 2012 ·Analytical Biochemistry ·Anatoly I. Dragan, Mark T. Albrecht, Radmila Pavlović, Andrea Keane‐Myers, Chris D. Geddes	30
9	A non-glycosylated, plant-produced human monoclonal antibody against anthrax protective antigen protects mice and non-human primates fromB. anthracisspore challenge 2011 ·Human Vaccines ·Vadim Mett, Jessica A. Chichester, Michelle L. Stewart, Konstantin Musiychuk, Hong Bi, (unknown), Anna K. Hull, Mark T. Albrecht, Stanley Goldman, Les Baillie, Vidadi Yusibov	24
10	In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants 2010 ·Molecular Pharmaceutics ·Eric M. Bachelder, Tristan T. Beaudette, Kyle E. Broaders, Jean M. J. Fréchet, Mark T. Albrecht, Alfred Mateczun, Kristy M. Ainslie, John Pesce, Andrea Keane‐Myers	109
11	Human Monoclonal Antibodies against Anthrax Lethal Factor and Protective Antigen Act Independently To Protect againstBacillus anthracisInfection and Enhance Endogenous Immunity to Anthrax 2007 ·Infection and Immunity ·Mark T. Albrecht, Han Li, E. Diane Williamson, (unknown), Helen C. Flick-Smith, Conrad P. Quinn, (unknown), Darrell R. Galloway, Alfred Mateczun, Stanley Goldman, Herman Groen, Les Baillie	84
12	Alginate Lyase (AlgL) Activity Is Required for Alginate Biosynthesis in Pseudomonas aeruginosa 2005 ·Journal of Bacteriology ·Mark T. Albrecht, Neal L. Schiller	52
13	Binding of protegrin-1 to Pseudomonas aeruginosa and Burkholderia cepacia 2002 ·Respiratory Research ·Mark T. Albrecht, Wei Wang, О. В. Шамова, Robert I. Lehrer, Neal L. Schiller	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact